UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Radiosurgery New York (RSNY) Demystifies Kinds of Prostate Cancer for Enhanced Patient Awareness NEW YORK, NY, USA, August 24, 2023/EINPresswire.com/ -- Radiosurgery ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

Cream cheese can upgrade just about any bagel to an entirely different level. However, that tasty cream cheese isn't always ...

Many clinicians who treat men with prostate cancer may be unfamiliar with the term "treatment-emergent small-cell neuroendocrine prostate cancer" (t-SCNC). That's because it has been considered a rare ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...